Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

I spent $40,000 and had not one single date. Afterward, meeting after they told me that they had lots of eligible men, they disclosed that all of the men they get are looking for women much much ...

Life on Earth may exist thanks to an incredible stroke of luck — a chemical sweet spot that most planets miss during their formation but ours managed to hit.